𝔖 Bobbio Scriptorium
✦   LIBER   ✦

14A A design for assessing clinical benefit for patients with advanced pancreatic cancer

✍ Scribed by John S. Andersen; Howard Burris; Ephraim Casper; Michael Clayman; Mark Green; Robert L. Nelson; Russell Portenoy; Mace Rothenberg; Peter G. Tarassoff; Daniel Von Hoff

Book ID
113297980
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
54 KB
Volume
15
Category
Article
ISSN
0197-2456

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction chemotherapy selects patients
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
✍ Sunil Krishnan; Vishal Rana; Nora A. Janjan; Gauri R. Varadhachary; James L. Abb πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract ## BACKGROUND. The current study was conducted to determine whether there were differences in outcome for patients with unresectable locally advanced pancreatic cancer (LAPC) who received treatment with chemoradiation therapy (CR) versus induction chemotherapy followed by CR (CCR). ##